PubMed:32471903 / 1337-1464
Annnotations
LitCovid-OGER-BB
{"project":"LitCovid-OGER-BB","denotations":[{"id":"T18","span":{"begin":0,"end":36},"obj":"CHEBI:35475"},{"id":"T19","span":{"begin":0,"end":36},"obj":"CHEBI:35475"},{"id":"T20","span":{"begin":38,"end":43},"obj":"CHEBI:35472"},{"id":"T21","span":{"begin":38,"end":43},"obj":"CHEBI:35472"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Non-steroidal anti-inflammatory drug (NSAID) use was not associated with hospitalisation status (OR 0.64, 95% CI 0.39 to 1.06)."}
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T14","span":{"begin":0,"end":127},"obj":"Sentence"},{"id":"T14","span":{"begin":0,"end":127},"obj":"Sentence"}],"text":"Non-steroidal anti-inflammatory drug (NSAID) use was not associated with hospitalisation status (OR 0.64, 95% CI 0.39 to 1.06)."}